738 Spurious Drugs Cases, 528 Put On Back Burner

Jaipur: The previous Congress government was apparently very kind to the traders selling death in name of medicine. The situation was such that during these five years, Dept. to control spurious medicines found 738 medicines to be of substandard grade in sample testing, but legal action was taken and challan presented only in 90 cases.

Laxity was shown in taking action against firms related to 89 medicines which were directly found to be fake in sample test. Of these, investigation of 64 medicines has not been completed till now while complaints filed only in 25 out of 89 cases.

The slow pace of probe during Cong govt points towards a nexus between govt machinery and pharma firms. In previous govt, responsibility of Drugscontrol Dept. was first with Raghu Sharma and later with Parsadilal Meena. However, pace of probe in these cases remained the same.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?